Citba Financial Corp is a financial service provider... Show more
CBAF saw its Momentum Indicator move above the 0 level on August 05, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 62 similar instances where the indicator turned positive. In of the 62 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 44 cases where CBAF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CBAF just turned positive on August 19, 2025. Looking at past instances where CBAF's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .
The 10-day RSI Indicator for CBAF moved out of overbought territory on August 21, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 51, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CBAF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.766) is normal, around the industry mean (1.131). P/E Ratio (8.634) is within average values for comparable stocks, (20.051). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.593). Dividend Yield (0.029) settles around the average of (0.037) among similar stocks. P/S Ratio (1.896) is also within normal values, averaging (5.166).
Industry RegionalBanks
A.I.dvisor tells us that CBAF and HBAN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CBAF and HBAN's prices will move in lockstep.
Ticker / NAME | Correlation To CBAF | 1D Price Change % | ||
---|---|---|---|---|
CBAF | 100% | N/A | ||
HBAN - CBAF | 29% Poorly correlated | +1.77% | ||
FITB - CBAF | 28% Poorly correlated | +1.13% | ||
SNV - CBAF | 27% Poorly correlated | -3.17% | ||
RF - CBAF | 27% Poorly correlated | +1.22% | ||
CFBK - CBAF | 27% Poorly correlated | -0.61% | ||
More |